359 related articles for article (PubMed ID: 26880678)
1. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
Drogan D; Schulze MB; Boeing H; Pischon T
Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
[TBL] [Abstract][Full Text] [Related]
2. Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients.
El-Mesallamy HO; Hamdy NM; Sallam AA
Acta Diabetol; 2013 Oct; 50(5):679-85. PubMed ID: 22307870
[TBL] [Abstract][Full Text] [Related]
3. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
[TBL] [Abstract][Full Text] [Related]
5. Decreased Serum IGF-1/IGFBP-3 Molar Ratio is Associated with Executive Function Behaviors in Type 2 Diabetic Patients with Mild Cognitive Impairment.
Huang R; Wang P; Han J; Xia W; Cai R; Sun H; Sun J; Wang S
J Alzheimers Dis; 2015; 47(1):85-94. PubMed ID: 26402757
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S
Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosis.
Mu F; Hankinson SE; Schernhammer E; Pollak MN; Missmer SA
Am J Epidemiol; 2015 Jul; 182(2):148-56. PubMed ID: 26121987
[TBL] [Abstract][Full Text] [Related]
8. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
[TBL] [Abstract][Full Text] [Related]
9. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
11. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
13. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.
Mikami K; Ozasa K; Nakao M; Miki T; Hayashi K; Watanabe Y; Mori M; Sakauchi F; Washio M; Kubo T; Suzuki K; Wakai K; Nakachi K; Tajima K; Ito Y; Inaba Y; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():57-61. PubMed ID: 20553083
[TBL] [Abstract][Full Text] [Related]
15. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182
[TBL] [Abstract][Full Text] [Related]
16. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
[TBL] [Abstract][Full Text] [Related]
17. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
[TBL] [Abstract][Full Text] [Related]
18. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
[TBL] [Abstract][Full Text] [Related]
19. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
Br J Cancer; 2007 Jul; 97(1):98-104. PubMed ID: 17533398
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death.
Lin Y; Tamakoshi A; Kikuchi S; Yagyu K; Obata Y; Ishibashi T; Kawamura T; Inaba Y; Kurosawa M; Motohashi Y; Ohno Y
Int J Cancer; 2004 Jul; 110(4):584-8. PubMed ID: 15122592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]